These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
442 related items for PubMed ID: 25787276
21. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma. Borozan I, Zapatka M, Frappier L, Ferretti V. J Virol; 2018 Jan 15; 92(2):. PubMed ID: 29093097 [Abstract] [Full Text] [Related]
22. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis. Weiss ER, Alter G, Ogembo JG, Henderson JL, Tabak B, Bakiş Y, Somasundaran M, Garber M, Selin L, Luzuriaga K. J Virol; 2017 Jan 01; 91(1):. PubMed ID: 27733645 [Abstract] [Full Text] [Related]
23. Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains. Brooks JM, Croom-Carter DS, Leese AM, Tierney RJ, Habeshaw G, Rickinson AB. J Virol; 2000 Feb 01; 74(4):1801-9. PubMed ID: 10644353 [Abstract] [Full Text] [Related]
24. Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Types. Feederle R, Klinke O, Kutikhin A, Poirey R, Tsai MH, Delecluse HJ. Curr Top Microbiol Immunol; 2015 Feb 01; 390(Pt 1):119-48. PubMed ID: 26424646 [Abstract] [Full Text] [Related]
25. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1. Nguyen-Van D, Ernberg I, Phan-Thi Phi P, Tran-Thi C, Hu L. Virus Genes; 2008 Oct 01; 37(2):273-81. PubMed ID: 18663567 [Abstract] [Full Text] [Related]
26. Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains. Kanda T, Furuse Y, Oshitani H, Kiyono T. J Virol; 2016 May 01; 90(9):4383-93. PubMed ID: 26889033 [Abstract] [Full Text] [Related]
27. Differences in EBNA2 and LMP-1 carboxy terminal region sequences of Epstein-Barr virus type A between the tumors in a multiple cancer patient. Higa M, Kinjo T, Miyagi J, Sakumoto N, Iwamasa T, Kishaba M, Sunakawa H. Pathol Res Pract; 2001 May 01; 197(6):401-9. PubMed ID: 11432667 [Abstract] [Full Text] [Related]
29. Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children. Ai J, Xie Z, Liu C, Huang Z, Xu J. Virol J; 2012 Jan 11; 9():13. PubMed ID: 22236445 [Abstract] [Full Text] [Related]
30. Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response. Bell MJ, Brennan R, Miles JJ, Moss DJ, Burrows JM, Burrows SR. J Infect Dis; 2008 Jun 01; 197(11):1594-7. PubMed ID: 18419576 [Abstract] [Full Text] [Related]
31. A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA. Majerciak V, Yang W, Zheng J, Zhu J, Zheng ZM. J Virol; 2019 Jan 15; 93(2):. PubMed ID: 30355690 [Abstract] [Full Text] [Related]
32. Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases. Wongwiwat W, Fournier B, Bassano I, Bayoumy A, Elgueta Karstegl C, Styles C, Bridges R, Lenoir C, BoutBoul D, Moshous D, Neven B, Kanda T, Morgan RG, White RE, Latour S, Farrell PJ. J Virol; 2022 Jun 22; 96(12):e0039422. PubMed ID: 35612313 [Abstract] [Full Text] [Related]
33. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population. Chou CC, Tsao CF, Liao CK, You HL, Wang MC, Huang WT. Exp Mol Pathol; 2021 Feb 22; 118():104577. PubMed ID: 33242451 [Abstract] [Full Text] [Related]
34. Determination and genome-wide analysis of Epstein-Barr virus (EBV) sequences in EBV-associated gastric carcinoma from Guangdong, an endemic area of nasopharyngeal carcinoma. Chen JN, Zhou L, Qiu XM, Yang RH, Liang J, Pan YH, Li HF, Peng GR, Shao CK. J Med Microbiol; 2018 Nov 22; 67(11):1614-1627. PubMed ID: 30239329 [Abstract] [Full Text] [Related]
35. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens. Tu C, Zeng Z, Qi P, Li X, Yu Z, Guo C, Xiong F, Xiang B, Zhou M, Gong Z, Liao Q, Yu J, He Y, Zhang W, Li X, Li Y, Li G, Xiong W. J Virol; 2017 Sep 01; 91(17):. PubMed ID: 28637758 [Abstract] [Full Text] [Related]
36. Sequence variation of EBNA2 of Epstein-Barr virus isolates from Korea. Shim YS, Kim CW, Lee WK. Mol Cells; 1998 Apr 30; 8(2):226-32. PubMed ID: 9638656 [Abstract] [Full Text] [Related]
37. Immunoinformatic Analysis Reveals Antigenic Heterogeneity of Epstein-Barr Virus Is Immune-Driven. Cirac A, Poirey R, Dieckmeyer M, Witter K, Delecluse HJ, Behrends U, Mautner J. Front Immunol; 2021 Apr 30; 12():796379. PubMed ID: 34975903 [Abstract] [Full Text] [Related]
38. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis. Tschochner M, Leary S, Cooper D, Strautins K, Chopra A, Clark H, Choo L, Dunn D, James I, Carroll WM, Kermode AG, Nolan D. PLoS One; 2016 Apr 30; 11(2):e0147567. PubMed ID: 26849221 [Abstract] [Full Text] [Related]